Rita Peters, Editorial Director for Pharmaceutical Technology and BioPharm Inernational talks with Alan Fisher of Dycem. They discuss how risk management can be applied to contamination control for pharmaceutical manufacturing and how risk can be measured. The discussion also covered the standards or practices that should guide facility operators in developing risk management strategies and the special risks facilities, particularly contract manufacturing operations, may may face and these risks might be mitigated.
Testing product and process intermediates alone is helpful, but does not provide a complete solution to viral safety. This article proposes integrated solutions for systemic and proactive viral risk mitigation.